Dynamics of HCV RNA Levels During Acute Hepatitis C Virus Infection

Journal of Medical Virology

Volumn 86, Issue 10, 2014, Pages 1722-1729

  Hajarizadeh, Behzad ^a   Grebely, Jason ^a   Applegate, Tanya ^a   Matthews, Gail V ^a   Amin, Janaki ^a   Petoumenos, Kathy ^a   Hellard, Margaret ^b   Rawlinson, William ^c   Lloyd, Andrew ^c   Kaldor, John ^a   Dore, Gregory J ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b BURNET INSTITUTE   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Alanine transaminase; Chronic; Persistent infection; Spontaneous clearance; Viral load

Indexed keywords

ALANINE AMINOTRANSFERASE; VIRUS RNA;

ADULT; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTRAVENOUS DRUG ABUSE; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; PERSISTENT INFECTION; PROSPECTIVE STUDY; VIRAL CLEARANCE; AUSTRALIA; BLOOD; LONGITUDINAL STUDY; TIME; VIROLOGY; VIRUS LOAD; YOUNG ADULT;

HEPATITIS C VIRUS;

ADULT; ALANINE TRANSAMINASE; AUSTRALIA; FEMALE; HEPATITIS C; HUMANS; LONGITUDINAL STUDIES; MALE; PROSPECTIVE STUDIES; RNA, VIRAL; TIME FACTORS; VIRAL LOAD; YOUNG ADULT;

EID: 84928341689     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24010     Document Type: Article

References (29)

1. Aberle JH, Formann E, Steindl-Munda P, Weseslindtner L, Gurguta C, Perstinger G, Grilnberger E, Laferl H, Dienes HP, Popow- Kraupp T, Ferenci P, Holzmann H. 2006. Prospective study of viral clearance and CD4+ T-cell response in acute hepatitis C primary infection and reinfection. J Clin Virol 36:24-31.
2. Barrera JM, Bruguera M, Ercilla MG, Gil C, Celis R, Gil MP, Del Onorato MV, Rodés J, Ordinas A. 1995. Persistent hepatitis C viremia after acute self-limiting posttransfusion hepatitis C. Hepatology 21:639-644.
3. Bull RA, Luciani F, McElroy K, Gaudieri S, Pham ST, Chopra A, Cameron B, Maher L, Dore GJ, White PA, Lloyd AR. 2011. Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection. PLoS Pathog 7:e1002243.
4. Dore GJ, Hellard M, Matthews GV, Grebely J, Haber PS, Petoumenos K, Yeung B, Marks P, van Beek I, McCaughan G, White P, French R, Rawlinson W, Lloyd AR, Kaldor JM. 2010. Effective treatment of injecting drug users with recently acquired hepatitis C virus infection. Gastroenterology 138:123-135.
5. Duggal P, Thio CL, Wojcik GL, Goedert JJ, Mangia A, Latanich R, Kim AY, Lauer GM, Chung RT, Peters MG, Kirk GD, Mehta SH, Cox AL, Khakoo SI, Alric L, Cramp ME, Donfield SM, Edlin BR, Tobler LH, Busch MP, Alexander G, Rosen HR, Gao X, Abdel-Hamid M, Apps R, Carrington M, Thomas DL. 2013. Genome-wide association study of spontaneous resolution of hepatitis C virus infection: Data from multiple cohorts. Ann Intern Med 158:235-245.
6. Farci P, Shimoda A, Coiana A, Diaz G, Peddis G, Melpolder JC, Strazzera A, Chien DY, Munoz SJ, Balestrieri A, Purcell RH, Alter HJ. 2000. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 288:339-344.
7. Garten RJ, Lai SH, Zhang JB, Liu W, Chen J, Yu XF. 2008. Factors influencing a low rate of hepatitis C viral RNA clearance in heroin users from Southern China. World J Gastroenterol 14: 1878-1884.
8. Glynn SA, Wright DJ, Kleinman SH, Hirschkorn D, Tu Y, Heldebrant C, Smith R, Giachetti C, Gallarda J, Busch MP. 2005. Dynamics of viremia in early hepatitis C virus infection. Transfusion (Paris) 45:994-1002.
9. Grebely J, Petoumenos K, Hellard M, Matthews GV, Suppiah V, Applegate T, Yeung B, Marks P, Rawlinson W, Lloyd AR, Booth D, Kaldor JM, George J, Dore GJ. 2010. Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection. Hepatology 52:1216-1224.
10. Grebely J, Matthews GV, Dore GJ. 2011. Treatment of acute HCV infection. Nat Rev Gastroenterol 8:265-274.
11. Grebely J, Feld JJ, Applegate T, Matthews GV, Hellard M, Sherker A, Petoumenos K, Zang G, Shaw I, Yeung B, George J, Teutsch S, Kaldor JM, Cherepanov V, Bruneau J, Shoukry NH, Lloyd AR, Dore GJ. 2013a. Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection. Hepatology 57:2124-2134.
12. Grebely J, Morris MD, Rice TM, Bruneau J, Cox AL, Kim AY, McGovern BH, Shoukry NH, Lauer G, Maher L, Lloyd AR, Hellard M, Prins M, Dore GJ, Page K. 2013b. Cohort profile: The international collaboration of incident HIV and hepatitis C in injecting cohorts (InC3) study. Int J Epidemiol 42:1649-1659.
13. Grebely J, Page K, Sacks-Davis R, van der Loeff MS, Rice TM, Bruneau J, Morris MD, Hajarizadeh B, Amin J, Cox AL, Kim AY, McGovern BH, Schinkel J, George J, Shoukry NH, Lauer GM, Maher L, Lloyd AR, Hellard M, Dore GJ, Prins M. 2014. The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology 59:109-120.
14. Hajarizadeh B, Grebely J, Dore GJ. 2013. Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol 10:553-562.
15. Lavillette B, Morice Y, Germanidis G, Donot P, Soulier A, Pagkalos E, Sakellariou G, Intrator L, Bartosch B, Pawlotsky JM, Cosset FL. 2005. Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection. J Virol 79:6023-6034.
16. Liu L, Fisher BE, Thomas DL, Cox AL, Ray SC. 2012. Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution. Hepatology 55:1684-1691.
17. Loomba R, Rivera MM, McBurney R, Park Y, Haynes-Williams V, Rehermann B, Alter HJ, Herrine SK, Liang TJ, Hoofnagle JH, Heller T. 2011. The natural history of acute hepatitis C: Clinical presentation, laboratory findings and treatment outcomes. Aliment Pharm Ther 33:559-565.
18. McGovern BH, Birch CE, Bowen MJ, Reyor LL, Nagami EH, Chung RT, Kim AY. 2009. Improving the diagnosis of acute hepatitis C virus infection with expanded viral load criteria. Clin Infect Dis 49:1051-1060.
19. Micallef JM, Kaldor JM, Dore GJ. 2006. Spontaneous viral clearance following acute hepatitis C infection: A systematic review of longitudinal studies. J Viral Hepat 13:34-41.
20. Nübling CM, Unger G, Chudy M, Raia S, Löwer J. 2002. Sensitivity of HCV core antigen and HCV RNA detection in the early infection phase. Transfusion (Paris) 42:1037-1045.
21. Page K, Hahn JA, Evans J, Shiboski S, Lum P, Delwart E, Tobler L, Andrews W, Avanesyan L, Cooper S, Busch MP. 2009. Acute hepatitis C virus infection in young adult injection drug users: A prospective study of incident infection, resolution, and reinfection. J Infect Dis 200:1216-1226.
22. Pham S, Bull R, Bennett J, Rawlinson W, Dore G, Lloyd A, White PA. 2010. Frequent multiple hepatitis C virus infections among injection drug users in a prison setting. Hepatology 52:1564- 1572.
23. Prokunina-Olsson L, Muchmore B, Tang W, Pfeiffer RM, Park H, Dickensheets H, Hergott D, Porter-Gill P, Mumy A, Kohaar I, Chen S, Brand N, Tarway M, Liu L, Sheikh F, Astemborski J, Bonkovsky HL, Edlin BR, Howell CD, Morgan TR, Thomas DL, Rehermann B, Donnelly RP, O'Brien TR. 2013. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet 45:164-171.
24. Smith JA, Aberle JH, Fleming VM, Ferenci P, Thomson EC, Karayiannis P, McLean AR, Holzmann H, Klenerman P. 2010. Dynamic coinfection with multiple viral subtypes in acute hepatitis C. J Infect Dis 202:1770-1779.
25. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. 2001. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 194:1395-1406.
26. Thomson EC, Fleming VM, Main J, Klenerman P, Weber J, Eliahoo J, Smith J, McClure MO, Karayiannis P. 2011. Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men. Gut 60:837-845.
27. Tillmann HL, Thompson AJ, Patel K, Wiese M, Tenckhoff H, Nischalke HD, Lokhnygina Y, Kullig U, Göbel U, Capka E, Wiegand J, Schiefke I, Güthoff W, Grüngreiff K, König I, Spengler U, McCarthy J, Shianna KV, Goldstein DB, McHutchison JG, Timm J, Nattermann J. 2010. A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice. Gastroenterology 139:1586-1592.
28. Weseslindtner L, Neumann-Haefelin C, Viazov S, Haberstroh A, Kletzmayr J, Aberle JH, Timm J, Ross SR, Klauser-Braun R, Baumert TF, Roggendorf M, Thimme R, Holzmann H. 2009. Acute infection with a single hepatitis C virus strain in dialysis patients: Analysis of adaptive immune response and viral variability. J Hepatol 50:693-704.
29. Zhang M, Rosenberg PS, Brown DL, Preiss L, Konkle BA, Eyster ME, Goedert JJ. 2006. Correlates of spontaneous clearance of hepatitis C virus among people with hemophilia. Blood 107:892- 897.